CELL CURE NEUROSCIENCES
Cell Cure Neurosciences Ltd. (Cell Cure) is developing cell therapies for retinal and neural degenerative diseases. Its therapeutic programs include OpRegen™ for retinal disease, and the development of neural progenitor cells for degenerative neurological disorders. Cell Cure’s pipeline of regenerative medicine therapies are derived from human embryonic stem cells (hESCs), pluripotent cells which are capable of morphing into all the cell types of the human body. Cell Cure is a majority-o... wned subsidiary of BioTime, Inc. and is the neurological arm for BioTime’s program for development of human embryonic stem cell-based therapies. Additional shareholders include Teva Pharmaceuticals and Hadasit Bio-Holdings. In October, 2010, Cell Cure entered into an exclusive license option agreement with Teva to develop and commercialize Cell Cure’s OpRegen™ product for the treatment of AMD. Subject to the terms of the agreement, if Teva exercises its option to obtain an exclusive license to OpRegen™, Teva will have responsibility for funding clinical trials from that point on, obtaining regulatory approvals, and marketing the product.
CELL CURE NEUROSCIENCES
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
2005-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.cellcureneurosciences.com
Total Employee:
1+
Status:
Closed
Contact:
972 5 4524 5677
Email Addresses:
[email protected]
Total Funding:
4.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx Amazon Google
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Office of the Chief Scientist
Office of the Chief Scientist investment in Grant - Cell Cure Neurosciences
Official Site Inspections
http://www.cellcureneurosciences.com
Unable to get host informations!!!
More informations about "Cell Cure Neurosciences"
Cell Cure Neurosciences Ltd. - LinkedIn
Cell Cure Neurosciences, a majority-owned (>95%) Israeli subsidiary of Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing novel cell therapies for …See details»
Cell Cure Neurosciences - Company Profile - Tracxn
Jan 28, 2025 Cell Cure Neurosciences is developing cell therapies for retinal and neurodegenerative diseases. Its proprietary platform uses and expands human Embryonic …See details»
Cell Cure Neurosciences - Funding, Financials, Valuation & Investors
Cell Cure Neurosciences offers cell therapies for retinal and neural degenerative diseases, such as OpRegen™, a retinal therapeutic program.See details»
Cell Cure Neurosciences - Overview, News & Similar companies
Jul 10, 2018 View Cell Cure Neurosciences (www.cellcureneurosciences.com) location in California, United States , revenue, industry and description. Find related and similar …See details»
Cell Cure Neurosciences - VentureRadar
"Cell Cure Neurosciences is a biotechnology company focused on developing cell therapies for retinal and neural degenerative disease. Our technology is based on human embryonic stem …See details»
Cell Cure Neurosciences Company Profile - Craft
See insights on Cell Cure Neurosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Cell Cure Neurosciences - Org Chart, Teams, Culture & Jobs | The …
View Cell Cure Neurosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Cell Cure Neurosciences Company Information - Funding, …
Cell Cure Neurosciences is a biotechnology company developing cell therapies using stem cells for treating retinal and neurodegenerative diseases.See details»
Cell Cure Neurosciences - Products, Competitors, Financials, …
Apr 18, 2023 About Cell Cure Neurosciences Cell Cure Neurosciences (Cell Cure) is focused on the development of cell therapies for neural degenerative diseases. Its therapeutic programs …See details»
Cell Cure Neurosciences Ltd - Company Profile and News
Company profile page for Cell Cure Neurosciences Ltd including stock price, company news, executives, board members, and contact informationSee details»
CellCure Neurosciences - Israeli Startup | Startup Nation Finder
Jun 18, 2017 Cell Cure Neurosciences is a biotechnology company developing cell therapies based on the use of human embryonic stem cells for the treatment of retinal and neural …See details»
Cell Cure Neurosciences 2025 Company Profile: Valuation, Funding ...
Dec 29, 2017 Information on valuation, funding, acquisitions, investors, and executives for Cell Cure Neurosciences. Use the PitchBook Platform to explore the full profile.See details»
Cell Cure Neurosciences Ltd. Information - RocketReach
Cell Cure Neurosciences Ltd. is a Biotechnology, Biotechnology Research, and Embryonic stem cell research & development company located in Jerusalem, Jerusalem with $5 million in …See details»
Cell Cure Neurosciences Ltd. profiles - FinalScout
Cell Cure Neurosciences is a biotechnology company focused on developing cell therapies for retinal and neural degenerative disease. Our technology is based on human embryonic stem …See details»
Cell Cure Neurosciences - Company info. interviews, news
Cell Cure Neurosciences Ltd. (Cell Cure) is developing cell therapies for retinal and neural degenerative diseases. Its therapeutic programs include OpRegen™ for retinal disease, and …See details»
Cell Cure Neurosciences Ltd., a Subsidiary of BioTime, Inc. and …
Oct 10, 2010 Hadasit is a subsidiary of Hadassah Medical Organization (“HMO”) and was established for the purpose of promoting and commercializing the intellectual property and …See details»
Cell Cure Neurosciences Ltd. Provides Update on its Product …
Feb 17, 2015 Cell Cure Neurosciences Ltd. is an Israel-based biotechnology company focused on developing stem cell-based therapies for retinal and neurological disorders.See details»
Cell Cure Neurosciences enters exclusive worldwide collaboration …
Jan 15, 2022 Lineage Cell Therapeutics, Inc. (NYSE and TASE: LCTX) and its subsidiary Cell Cure Neurosciences, Ltd, recently entered into an exclusive worldwide collaboration and …See details»
Cancer research needs neuroscience and neuroscientists - Nature
4 days ago The nervous system can drive the initiation, growth, spread, and therapy resistance of cancer, and cancer can manipulate the nervous system in ways that further support disease …See details»
Cell Cure Neurosciences - Contacts, Employees, Board
Cell Cure Neurosciences offers cell therapies for retinal and neural degenerative diseases, such as OpRegen™, a retinal therapeutic program.See details»